Global Bilirubin Blood Test Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Danaher Corp. | Technavio
LONDON--(BUSINESS WIRE)--Jan 28, 2020--
Technavio has been monitoring the global bilirubin blood test market since 2019 and the market is poised to grow by USD 562.5 million during 2020-2024, progressing at a CAGR of almost 8% during the forecast period. Request free sample pages
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200128005511/en/
Technavio has announced its latest market research report titled global bilirubin blood test market 2020-2024 (Graphic: Business Wire)
Read the 145-page report with TOC on “Bilirubin Blood Test Market Analysis Report by Type (Infants and Adults), Geography (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2020-2024”.
The market is driven by the increasing prevalence of jaundice and liver diseases. In addition, the increasing demand for non-invasive procedures is anticipated to boost the growth of the bilirubin blood test market.
High bilirubin levels are most common in newborns. This is because of the immature liver in neonates and the rapid breakdown of red blood cells. The imbalance between bilirubin production and conjugation results in increased bilirubin levels, thereby causing neonatal jaundice. This has increased the demand for bilirubin testing products. Bilirubin testing products are also used in the diagnosis of other conditions such as anemia and liver diseases. In 2018, nearly 4.5 million adults in the US were diagnosed with liver diseases. Therefore, with the growing prevalence of jaundice and liver diseases, the demand for bilirubin testing products will increase significantly during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Bilirubin Blood Test Market Companies:
Abbott Laboratories operates its business through segments such as Established Pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and Neuromodulation. Total Bilirubin assay and ARCHITECT c8000 System are the key offerings of the company.
Danaher Corp. operates its business through segments such as Life Sciences, Diagnostics, Dental, and Environmental and Applied Solutions. Total Bilirubin reagent OSR6512, Direct Bilirubin reagent OSR6511, and AU680 clinical chemistry analyzer are the key offerings of the company.
Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA offers a wide range of bilirubin blood test products. Dräger Jaundice Meter JM-103 is one of its key offerings. It is a hand-held transcutaneous bilirubin meter used for testing bilirubin level in infants.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. operates its business through segments such as Pharmaceuticals and Diagnostics. Cobas c 501 is the key offering of the company. It is a mid-volume analyzer module for clinical chemistry for the determination of sodium, potassium, and chloride in serum, plasma, or urine.
Koninklijke Philips NV
Koninklijke Philips NV operates its business through segments such as Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and HealthTech Other. BiliChek System is the key offering of the company. It is a non-invasive jaundice assessment device for newborns.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio has segmented the bilirubin blood test market based on the type and region.
Bilirubin Blood Test Type Outlook (Revenue, USD Million, 2020 - 2024)
Bilirubin Blood Test Regional Outlook (Revenue, USD Million, 2020 - 2024)
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Related Reports on Healthcare are:
Global C-Reactive Protein Test Market – Global C-reactive protein test market by end-users (hospitals, clinical laboratories, and others) and geography (Asia, Europe, North America, and ROW).
Global Anti-Thrombin III Testing Market – Global anti-thrombin III testing market by end-users (hospitals, laboratories, and academic and research institutes) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20200128005511/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL DEVICES OTHER HEALTH HEALTH PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2020.
PUB: 01/28/2020 05:00 PM/DISC: 01/28/2020 05:00 PM